We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.57M
Cap. Flow %
-2.89%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

Rank Stock Value
1
XFLT
XAI Floating Rate & Alternative Income Trust
XFLT
+$689K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
+$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$468K
4
ENIC icon
Enel Chile
ENIC
+$430K
5
EFT
Eaton Vance Floating-Rate Income Trust
EFT
+$429K

Top Sells

Rank Stock Value
1
GRA
W.R. Grace & Co.
GRA
+$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
+$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
+$693K
4
NOA
North American Construction
NOA
+$554K
5
MCI
Barings Corporate Investors
MCI
+$524K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKRO
326
DELISTED
Akero Therapeutics
AKRO
$160K 0.07%
7,146
-380
-5% -$8.6K
MTEM
327
DELISTED
Molecular Templates, Inc.
MTEM
$160K 0.07%
1,587
-83
-5% -$8.56K
KROS icon
328
Keros Therapeutics
KROS
$199M
$159K 0.07%
4,016
-213
-5% -$7.58K
MDGL icon
329
Madrigal Pharmaceuticals
MDGL
$12.4B
$158K 0.07%
1,976
-102
-5% -$8.81K
AFMD
330
DELISTED
Affimed
AFMD
$157K 0.07%
2,542
-134
-5% -$8.82K
BCAB icon
331
BioAtla
BCAB
$5.86M
$157K 0.07%
107
-5
-4% -$9.74K
BBIO icon
332
BridgeBio Pharma
BBIO
$16.8B
$156K 0.07%
3,336
-173
-5% -$9.27K
CGEM icon
333
Cullinan Oncology
CGEM
$1.07B
$156K 0.07%
6,925
-356
-5% -$9.52K
CMRX
334
DELISTED
Chimerix, Inc.
CMRX
$156K 0.07%
25,153
-1,319
-5% -$9.07K
TSHA icon
335
Taysha Gene Therapies
TSHA
$1.57B
$154K 0.07%
8,268
-429
-5% -$8.15K
ALDX icon
336
Aldeyra Therapeutics
ALDX
$95.3M
$152K 0.07%
17,296
-905
-5% -$8.31K
STTK icon
337
Shattuck Labs
STTK
$651M
$152K 0.07%
7,462
-392
-5% -$8.39K
PRVB
338
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$151K 0.07%
23,667
-1,242
-5% -$7.98K
ARWR icon
339
Arrowhead Research
ARWR
$12.1B
$150K 0.07%
2,403
-127
-5% -$8.22K
KRRO icon
340
Korro Bio
KRRO
$151M
$150K 0.07%
426
-22
-5% -$8.66K
PGEN icon
341
Precigen
PGEN
$1.97B
$150K 0.07%
30,149
-1,580
-5% -$9.1K
RETA
342
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$150K 0.07%
1,486
-74
-5% -$8.67K
CGEN icon
343
Compugen
CGEN
$214M
$149K 0.07%
24,979
-1,306
-5% -$8.75K
CTMX icon
344
CytomX Therapeutics
CTMX
$701M
$149K 0.07%
29,358
-1,538
-5% -$8.23K
VOR icon
345
Vor Biopharma
VOR
$1.08B
$149K 0.07%
477
-24
-5% -$7.13K
APLT
346
DELISTED
Applied Therapeutics
APLT
$146K 0.06%
8,790
-457
-5% -$7.89K
IGMS
347
DELISTED
IGM Biosciences
IGMS
$146K 0.06%
2,213
-115
-5% -$8.8K
PASG icon
348
Passage Bio
PASG
$14.7M
$146K 0.06%
734
-39
-5% -$9.3K
DNLI icon
349
Denali Therapeutics
DNLI
$3.82B
$143K 0.06%
2,830
-150
-5% -$8.45K
WVE icon
350
Wave Life Sciences
WVE
$1.13B
$143K 0.06%
29,090
-1,510
-5% -$9.15K
12 13
14
15 16

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Virtus ETF Advisers held 407 positions worth $227M, down 6.5% from $243M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.4%. Virtus ETF Advisers opened 8 new positions and exited 10, leaving the 407-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Real Estate and Energy.

  • Virtus ETF Advisers's largest Q3 2021 buy was XAI Floating Rate & Alternative Income Trust: 15,447 shares worth $663K.
  • Virtus ETF Advisers added most to Enel Chile in Q3 2021, an estimated $430K increase.
  • Virtus ETF Advisers's biggest Q3 2021 reduction was North American Construction, cutting an estimated $554K.
  • Virtus ETF Advisers fully exited W.R. Grace & Co. in Q3 2021, selling an estimated $1.73M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $227M portfolio in Q3 2021.
  • Virtus ETF Advisers opened 8 new positions and closed 10 in Q3 2021.
  • Virtus ETF Advisers's portfolio value fell 6.5% quarter-over-quarter to $227M.

Based on Virtus ETF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.